March 16, 2023

Growing body of data supports Ampligen’s potential as both a prophylactic and an early-onset therapy against human Ebola virus disease outbreaks OCALA, Fla., March 16, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics

IBFD Masterclass: Tax Structuring in Africa – Selected Critical Issues AMSTERDAM, March 16, 2023 (GLOBE NEWSWIRE) —IBFD will host the Masterclass: Tax Structuring in Africa – Selected Critical Issues, on 22-23 May 2023 in Arusha, Tanzania for African tax practitioners. This advanced-level training will provide participants with a platform to learn,